Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Amortization of Deferred Charges: 2014-2025

Historic Amortization of Deferred Charges for Rockwell Medical (RMTI) over the last 9 years, with Sep 2025 value amounting to $89,000.

  • Rockwell Medical's Amortization of Deferred Charges rose 1.14% to $89,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $354,000, marking a year-over-year decrease of 69.69%. This contributed to the annual value of $426,000 for FY2024, which is 61.52% down from last year.
  • Rockwell Medical's Amortization of Deferred Charges amounted to $89,000 in Q3 2025, which was up 1.14% from $88,000 recorded in Q2 2025.
  • Over the past 5 years, Rockwell Medical's Amortization of Deferred Charges peaked at $831,000 during Q4 2023, and registered a low of $30,000 during Q2 2024.
  • Moreover, its 3-year median value for Amortization of Deferred Charges was $89,000 (2025), whereas its average is $163,455.
  • As far as peak fluctuations go, Rockwell Medical's Amortization of Deferred Charges surged by 793.55% in 2023, and later crashed by 89.29% in 2024.
  • Quarterly analysis of 5 years shows Rockwell Medical's Amortization of Deferred Charges stood at $93,000 in 2021, then remained steady at $93,000 in 2022, then soared by 793.55% to $831,000 in 2023, then tumbled by 89.29% to $89,000 in 2024, then climbed by 1.14% to $89,000 in 2025.
  • Its last three reported values are $89,000 in Q3 2025, $88,000 for Q2 2025, and $88,000 during Q1 2025.